In patients experiencing acute pain, how does the efficacy and gastrointestinal tolerability of tapentadol compare with oxycodone?

MOspace/Manakin Repository

Breadcrumbs Navigation

In patients experiencing acute pain, how does the efficacy and gastrointestinal tolerability of tapentadol compare with oxycodone?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/10203

[+] show full item record


Title: In patients experiencing acute pain, how does the efficacy and gastrointestinal tolerability of tapentadol compare with oxycodone?
Author: Wilhorn, Samantha; Kraus, Connie
Date: 2011-03
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 14(3): 14.
Abstract: The analgesic effect of tapentadol (Nucynta®) immediate release (IR) 50 and 75 mg are comparable to oxycodone IR 10 mg, and tapentadol IR 100 mg to oxycodone IR 15 mg, for the treatment of acute pain. Tapentadol is associated with less nausea or vomiting than oxycodone at equianalgesic doses. (SOR: B, based on evidence from RCTs.)
URI: http://hdl.handle.net/10355/10203

This item appears in the following Collection(s)

[+] show full item record